They also suggested that HSP70 expression inducers, such as valproic acid or geranylgeranylacetone (GGA), could be candidate therapeutic agents for the prevention of retinal degenerative diseases, including retinitis pigmentosa. The gene discussed is HSPA4; the disease is retinitis pigmentosa.